semaglutide alzheimer phase 3 evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, studies evaluating efficacy, safety, and tolerability of in early-stage symptomatic Alzheimer's disease | Alzheimer's Research & Therapy GLP-1 Semaglutide Fails to Outperform

doi: 10.1038/nature09973 293 WhillierS.RaftosJ

GLP-1 receptors are expressed in the hypothalamus, hippocampus, cortex, amygdala, ventral tegmental area, nucleus accumbens, and lateral septum, with the highest density in the lateral septum

To evaluate inter-study statistical heterogeneity, we calculated I2 parameters, with values exceeding 50% indicative of noteworthy heterogeneity

But we dont have enough evidence to say it treats any specific condition. So, what is L-theanine, and is it worth trying

No one says they are stuck on antidepressants, inhalers, or statins

Is there clinical evidence that GLP-1 medications harm fetal development